dual acetylcholinesterase/amyloid beta aggregation inhibitors (Xinyang Normal University/Northwest A&F University)

N/A

Report date: 2025/01/26 18:03:33
NME

Base Information

Drug Namedual acetylcholinesterase/amyloid beta aggregation inhibitors (Xinyang Normal University/Northwest A&F University)
Drug Alias Namedual AChE/A-beta aggregation inhibitors (Xinyang Normal University/Northwest A&F University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsAcetylcholinesterase inhibitors
TargetsAcetylcholinesteraseBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXinyang Normal University
China Registration ClassN/A

Develop Information

Active CompaniesXinyang Normal UniversityNorthwest A&F University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A